Celeport
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
This study found that pretreatment with 4-(o-benzylphenoxy)-N-methylbuty-lamine hydrochloride (bifemelane hydrochloride, Celeport…
The therapeutic effect of bifemerane hydrochloride (Celeport®) was studied in 42 patients with loss of the sense of smell caused…
The clinical effect of Celeport® was evaluated in 55 patients (mean age: 67 years), complaining of chronic dizziness or imbalance…
In a pilot study to investigate the clinical effect of Celeport® on tinnitus, we administered 3 tablets per day (150 mg in 3…
The therapeutic effect of bifemelane hydrochloride was studied in 38 patients over 50 years of age with tinnitus. The patients…
4-(o-Benzylphenoxy)-N-methylbutylamine hydrochloride (bifemelane, CAS 90293-01-9, Celeport) has been reported to exert a…